News
Roche and partner Alnylam said on Tuesday their experimental drug against high blood pressure was shown to work when used in combination with the standard of care in a phase 2 trial.
Roche Holding AG anunció que ha acordado comprar InterMune Inc. por US$8.300 millones en efectivo, lo que supone la mayor transacción en años para el gigante farmacéutico suizo tras una serie ...
A group of advisers to the Food and Drug Administration said Roche Holding AG needs to study its blood cancer treatment in more American patients before its use can be expanded.
Venclexta trial deaths force AbbVie, Roche to stop recruiting myeloma patients The treatment achieved blockbuster status in 2020 and generated sales of $2.6 billion last year, an increase of 13% ...
Por Emma Thomasson BASILEA, 26 jul (Reuters) – La farmac (c)utica suiza Roche Holding dijo el jueves que asumi ‘ cargos por reestructuraci ‘n de 1.700 millones de d ‘lares, … ...
Roche executives insist that fears Genentech's informal culture will be destroyed when the suits ... Genentech culture in no danger from Roche, execs say. By Reuters. February 6, 2009 7:28 PM UTC ...
Roche, ViiV Healthcare and Horizon Therapeutics topped the list while Pfizer slipped from the highest tier, according to patient groups and compiled in a report by U.K. consultancy PatientView. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results